AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
3.630
+0.230 (6.76%)
At close: Jan 22, 2026, 4:00 PM EST
3.600
-0.030 (-0.83%)
After-hours: Jan 22, 2026, 4:25 PM EST
AC Immune Market Cap
AC Immune has a market cap or net worth of $359.16 million as of January 22, 2026. Its market cap has increased by 20.73% in one year.
Market Cap
359.16M
Enterprise Value
228.98M
1-Year Change
20.73%
Ranking
Category
Stock Price
$3.63
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $359.16M, a decrease of -58.60%. That is a compound annual growth rate of -9.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 343.00M | 8.27% |
| Dec 31, 2025 | 316.80M | 17.51% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
| Sep 23, 2016 | 867.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allogene Therapeutics | 359.57M |
| Foghorn Therapeutics | 356.18M |
| Tectonic Therapeutic | 351.96M |
| Aura Biosciences | 348.00M |
| Puma Biotechnology | 347.19M |
| Candel Therapeutics | 345.86M |
| Aardvark Therapeutics | 344.45M |
| XOMA Royalty | 337.69M |